4.6 Article

Prevalence of metabolic syndrome among middle-aged and elderly adults in China: current status and temporal trends

Journal

ANNALS OF MEDICINE
Volume 50, Issue 4, Pages 345-353

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/07853890.2018.1464202

Keywords

Metabolic syndrome; prevalence; trends; epidemiology

Funding

  1. Ministry of Finance of the People's Republic of China [61]
  2. Fundamental Research Funds for the Central Universities, Huazhong University of Science and Technology, Wuhan, China [2016YXMS215]
  3. China Postdoctoral Science Foundation [2017M622466]

Ask authors/readers for more resources

Background: Metabolic syndrome (MetS) is a duster of major risk factors for cardiovascular diseases. We aimed to estimate prevalence and distribution of MetS among middle-aged and elderly adults in China. Methods: The present analysis used data from a national study in 2014-2015. We defined MetS by different definitions, and compared results of the present study and previous nationally representative studies to illustrate possible temporal changes in MetS prevalence. Results: The estimated prevalence of MetS was 18.4% by the ATP III criteria, 34.0% by the revised ATP III criteria, and 26.9% by IDF criteria. The prevalence was higher in women, older adults, those with lower education level, and in economically developed regions. Contrasting with previous national studies, adults in urban areas had a lower rate of MetS than those in rural areas (odds ratio 0.94; 95% CI 0.92-0.97). Rural adults had worse deterioration or less improvement in abdominal obesity, overweight, hypertension, and high fasting plasma glucose, than urban adults, which was particularly striking for women. Conclusion: While measures to prevent and control cardiovascular diseases need to be strengthened in China, rapid increasing risk factors among rural residents and women should be prioritized in making public health policy decisions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available